Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,873,269
-$973,040 QoQ
Shares Held
2,428,717
+0.6% QoQ
Ownership
0.941%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 26.74564389346309.ToString("F0")%
Shared 0.ToString("F0")%
None 73.25435610653692.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. MRVI ranks #180 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in MRVI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,873,269 | 2,428,717 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,846,309 | 2,414,249 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,850,776 | 2,387,030 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,738,959 | 2,381,311 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,026,126 | 2,726,754 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,155,343 | 2,780,797 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,858,923 | 2,750,773 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,812,514 | 2,767,111 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,654,495 | 2,036,274 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,200,660 | 2,015,368 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,074,990 | 1,807,499 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $22,802,747 | 1,834,493 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,784,956 | 1,840,468 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,875,184 | 1,808,189 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $44,804,537 | 1,754,976 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $49,685,908 | 1,748,888 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $63,849,880 | 1,810,317 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $67,418,482 | 1,609,033 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $68,067,825 | 1,386,875 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $50,926,624 | 1,220,384 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $23,113,573 | 648,529 | Shares | Defined | 2021-07-09 | |
| No filing history on record for this holder in this stock. | ||||||